News
Zacks.com on MSN2d
Ultragenyx (RARE) Surges 5.1%: Is This an Indication of Further Gains?Ultragenyx (RARE) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings ...
AAV Group JSC Annual stock financials by MarketWatch. View the latest AAV financial statements, income statements and financial ratios.
Solid Biosciences' DMD gene therapy shows promise with SGT-003 and strong cash backing through 2027. Click here to read an ...
Zacks Investment Research on MSN12d
Bio-Techne's New USP Deal on mAb and Gene Therapy May Boost Its StockBio-Techne Corp. TECH has recently entered into a distribution agreement with the U.S. Pharmacopeia (“USP”) to sell USP monoclonal antibody (mAb) and recombinant adeno-associated virus (AAV) reference ...
The deal gives AstraZeneca’s rare disease unit Alexion access to specialized capsids developed by the Japanese biotech JCR ...
USP's well-characterized mAb and AAV standards, when paired with Bio-Techne's MauriceFlex system, enable efficient analysis of purity, size, charge, and identity in complex biologics.
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) is one of the 13 Best Long-Term Penny Stocks to Buy According to Analysts. In a report released on June 11, Maury Raycroft from Jefferies maintained a Buy ...
View the latest Asia Aviation PCL (AAV) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback